A.TIP ALANINDA ULUSLARARASI BİLİMSEL YAYINLAR

1) Ertan A, Arimura A, Akdamar K, Shibata T, Groot K, Luciano M, Mather F,   Değertekin H, Agrawal N, Ryan J.: Pancreatic immunoreactive somatostatin and diabetes mellitus. Dig.Dis. and Sci.,29,7,635,1984.

 

2) Değertekin H, Erten A, Akdamar Y, Yates R, Chen I, Coy DH, Arimura A.:Effects of somatostatin and a somatostatin agonist on diet-induced pancreatitis in mice. Peptide, 6, 1245,1985.

3) Değertekin H, Ertan A, Yates R, Van Mater K, Akdamar K.: Hyperbaric oxygen,allopurional and diet-induced acute pancreatitis. Ann of Int.Med., 103, 3,  474, 1985.

4) Değertekin H, Kestellioğlu F.: The prevalence of HBsAg in healthy people and  several liver diseases in Turkey. Asian Med.J., 29,2,125, 1986. 

 

5) Değertekin H, Akdamar K, YAtes R, Chen I, Ertan A, Vaupel R.: Light and  electron microscopic studies of diet-induced hepatic changes in mice. Acta Anat., 125, 174, 1986.

6) Ertan A, Değertekin H, Akdamar K, Godiwala T, Mather F.: A new criterion in the assesment of bentiromide as a test of exocrine pancreatic function in alcoholics. Pancreas, 1, 176, 1986.

7) Değertekin H, Ertan A, Akdamar K, Groot K, Godiwala T, Mather F, Arimura A.:Luminal gastric somatostatin-like immunoreactivity in response to various stimuli in man. Dig. Dis. and Sci., 31, 833, 1986.

8) Arimura A, Minamino N, Uehara A, Groot K, Değertekin H, Özden A, Akdamar K,Rossowski W, and Ertan A.: Somatostatin, CRF and GRF in the gastrointestinal tract. Proceedings, 159-1666, 1987, Thailand.

9) Özden A, Değertekin H, Yeginsu O, Ertan A.: Mechanism of release of gastric  luminal somatostatin-like immunoreactivity in response to pentagastrin and sham feeding in man. Scand. J. of Gastroenterol. 22, 1257-1262, 1987.

 

10)Ertan A, Özden A, Golodner E, Değertekin H, Arimura A.: Gastric luminal  somatostatin secretion of normals and patients with pernicious anemia and with Zollinger-Ellison syndrome. Dig. Dis and Sci., 33, 1596-1600, 1988.

 

11)Yılmaz A, Tez M, Değertekin H.: Comparison of NMR water proton T 1   measurement in healthy and pathological blood. Spectroscopy. Letters, 22(7),925-933, 1989.

 

12) Göral V, Değertekin H, Aksoy N.: Colchicine in treatment of cirrhosis of  liver. Doğa, T.J. of Med. Sci., 16, 583-584, 1992.

 

13) Göral V, Turhanoğlu M, Değertekin H, et al.: The prevalence of helicobacter  pylori in upper gastrointestinal diseases. JİMA, 24, 53-57, 1992.

 

14) Göral V, Değertekin H, Canoruç F. et al.: Endoscopic features of esophageal varices according to the Japanase despcription in cirrhosis. Lebertumoren und portal hypertension, Springer-Verlag, Heidelberg. 352-354, 1992.

 

15) Göral V, Değertekin H, Turfan M, et al.: The types of acute viral hepatitides in Turkey. JİMA, 25, 60-62, 1993.

 

16) Değertekin H, Göral V, Turhanoğlu M, Arıkan E.: The role of HCV in the etiology of liver cirrhosis in southeast Turkey. JİMA, 26, 28-30, 1994.

 

17) Göral V, Değertekin H, Canoruç F.: Asbestosis and gastrointestinal cancer in Southeast Turkey. Gastroenterology. Vol 112, 11.4, pp A.570, 1997.

 

18) Değertekin, H., A.Tuzcu, K. Yalçın, “Horizontal transmission of HBV  infection among students in Turkey, “Public Health, 114, 411-442,2000.

 

19) Değertekin, H., Y.Sari, K. Yalçın, Y. Akgun, “The age and sex distribution of colorectal carcinoma cases in Turkey, “Hepato-Gastroenterol, 47,32,2000.

 

20) Uzunalimoglu O, Yurdaydin C, Cetinkaya H, Bozkaya H, Sahin T, Colakoglu S, Tankurt E, Sarioglu M, Ozenirler S, Akkiz H, Tozun N, Degertekin H, Okten A.Risk factors for hepatocellular carcinoma in Turkey. Dig Dis Sci. 2001 May;46(5):1022-8.

 

21) Değertekin. H., K.Yalçin, R.Işık, “Peritoneal mesothelioma associated with exposure to asbestos in Southeastern Turkey, “J Clin Gastroenterol, 35, 409,  2002.

 

22) Yalçin, K. ve H Degertekin , “A 12-Month course of combination therapy with  interferon-alpha and ribavirin in chronic  hepatitis due to coinfection with  hepatitis B and C viruses, “Clin Drug Invest, 22, 797-798, 2002.

 

23) Yalçin, K., H.Degertekin, F. Yildiz, Z. Akkuş, “A 12-Month course of  combination therapy with interferon-alfa and lamivudine in patients with chronic hepatitis Delta virus: A single-center, prospective, open label,uncontrolled study, “Curr. Ther. Res, 63, 736-747, 2002.

 

24) Yalçin, K., H.Degertekin, F. Yildiz, Y.Celik, “ Markers of disease activity in chronic hepatitis B virus infection, “Clin Invest Med, Feb; 26, 27-34, 2003.

 

25) Yalcin, K., H. Degertekin, F. Yildiz ve Y. Celik, ‘‘Twelve month courses of interferon alpha-2b and lamivudine in combination compared to interferon alpha-2b monotherapy in patients with untreated HBeAg-positive chronic hepatitis B,’’ Clin Infect Dis, 36, 1516-22, 2003.

26) Yalcin, K., R. Danis, H. Degertekin, M.N. Alp, S. Tekes ve T. Budak, ‘‘The lack of effect of therapeutic vaccination with a preS2/S HBV vaccine in the immune tolerant phase of chronic HBV infection,’’ J Clin Gastroenterol, 37, 330-5, 2003.

27) Yalcin, K., M. Acar ve H. Degertekin, ‘‘Specific vaccine therapy in inactive HBsAg carriers by recombinant hepatitis B vaccine: A randomised controlled trial,’’ Infection, 31, 221-5 (2003).

28) Yalcin, K., H. Degertekin, C. Yurdaydin, M. Bozdayi ve H. Bozkaya, ‘‘The role of HBeAg seroconversion in acute exacerbation of liver disease with termination of hepatitis B and D virus infection in a chronic hepatitis D patient during alpha-interferon therapy,’’ Eur J Gastroenterol Hepatol, 15, 820-3 (2003).

29) Yalçın, K., H. Değertekin, F. Yıldız ve N. Kılınç, ‘‘A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with α–interferon and ribavirin,’’ J Gastroenterol, 38, 796-800 (2003).

30)  Yalcin, K., H. Degretekin ve M. Bozdayi, ‘‘A late failure of combined recombinant hepatitis B vaccine and lamivudine in treatment of a patient with chronic hepatitis B,’’ South Med J, (2003). (Yayın için kabul edilmiş)

 

31) Yalcin, K., H. Degertekin, I.H. Bahcecioglu, A. Demir, M. Aladag, B. Yildirim, S. Horasanli, S. Ciftci ve S. Badur, ‘‘Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT lvels in Turkey,’’ Infection, (2003). (Yayın için kabul edilmiş)

32) Yalcin, K., A. Bilici, O. Ayyildiz, H. Degertekin ve, E. Muftuoglu, ‘’Imaging of subcapsular liver hematoma and hepatic infarction in pregnancy complicated by the HELLP syndrome: a case report,’’ Eur J Radiol, (2003). (Yayın için kabul edilmiş)

33) Yalçın, K, Değertekin H, Yıldız F , Kılınç N.  A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with α–interferon and ribavirin.  J Gastroenterol, 2003; 38: 796-800

34)  Yalcin, K, Degertekin H , Bozdayi M. A late failure of combined recombinant hepatitis B vaccine and lamivudine in treatment of a patient with chronic hepatitis B.  South Med J, 2004; 97: 407-409

35) Yalcin, K,Degertekin H, Bahcecioglu IH, Demir A, Aladag M, Yildirim B, Horasanli S, Ciftci S , Badur S. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey. Infection, 2004; 32: 24-29 

36) Yalcin, K,Bilici A,  Ayyildiz O, Degertekin  H, Muftuoglu E, ‘Imaging of subcapsular liver hematoma and hepatic infarction in pregnancy complicated by the HELLP syndrome: a case report.  Eur J Radiol,2004;50: 21-26

37) Kılınç N, Yalcin K, Degertekin H, Özaydın M. Clear cell carsinoma of the liver: A case report, Turk J Gastroenterol, 2003; 14: 211-214

38) Yalcin K, Degertekin H,  Alp MN, Tekes S, Satıcı O, Budak T. Determination of serum hepatitis B virus DNA in chronic HbsAg carriers. Turk J Gastroenterol, 2003; 14: 157-163

39) Yalcin K, Degertekin H, Kökoglu ÖF,Ayaz C. A three-month course of lamivudine therapy in HbeAg-positive hepatitis B patients with normal aminotransferase levels. Turk J Gastroenterol, 2004; 15: 21-26

40) Soyoral Y, Süner A, Kıdır V, Arıtürk Z, Balakan O, Degertekin H. The effects of viral cirrhosis on cardiac ventricular function. Eur J Gen Med 2004; 1 (2):15-18

41) Erkan G, Sayın I,  Değertekin H et.all. The relationship between insulin resistance, metabolic syndrom and nonalcoholic fatty liver disease in non- obes, non-diabetic Turkish individuals. Turk J Gastroenterol. Suppl. 1:63-68, 2014

42) Akpınar EE, Gülhan M, Değertekin H, Ataoğlu Ö.  Thorax as an exstraintestinal target for inflammatory bowel dTuberk Toraks. 59(3): 312-5, 2011

43) Wedemeyer H, Yurdaydın C, Degertekin H. et all. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med 364(4)322-31,2011

44) Zachou K, Yurdaydın C, Degertekin H. Et all. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int., 30(3): 430-7, 2010

45) Degertekin H, Yalçın K, Yakut M, Yurdaydın C. Seropositivity for delte hepatitis in patients with chronic hepatitis B and liver crrhosis in Turkey: a meta-analysis. Liver Int. 28(4):494-8, 2008

46) Degertekin H, Yalçın K, Yakut M. The prevalence of hepatitis delta virus infectionin acute and chronic liver disease in Turkey:an analysis of clinical studies. Turk J Gastroenterol. 17(1):25-34,2006

47) Yalçın K, Degertekin H, Kokoglu OF, Ayaz C.A three-month coruce of lamivudine therapy in HBeAg positivehepatitis B patients with normal aminotransferase levels.Turk J Gastroenterol. Mar; 15(1): 14-20

48) Yalçın K, Degertekin H, Bozdayı M. Late failure of combined recombinant hepatitis B vaccine and lamivudine in treatment of patients with chronic hepatitis B. South Med J. Apr;97(4):407-9

 

B. GASTROENTEROLOJİ ALANINDA BİLİMSEL

     KİTAPLAR

 

1.Klinik Gastroenteroloji. Doç. Dr. Halil Değertekin. G.L Bongiovanni (İngilizceden çeviri). Dicle Üniversitesi Yayını, 1987.

2.Gastroenteroloji. Ed. Prof. Dr. Hamdi Aktan, Ankara, 1988.

3.Helikobakter Pilori. Ed. Prof. Dr. Ali Özden, Ankara,1995.

4.Viral Hepatit 98. Ed. Prof. Dr. Kaya Kılıçturgay, İstanbul, 1998.

5.Gastroenteroloji. Ed. Prof. Dr. Ali Özden, Ankara, 2002.

6.Hepatit B. Ed. Prof. Dr. Yılmaz Çakaloğlu, Prof. Dr. Atilla Ökten.  İstanbul, 2003

7.Türkiye’de Delta Hepatiti. Ed. Prof. Dr. Halil Değertekin, Prof. Dr.  Kendal Yalçın, Diyarbakır, 2005

8.Kronik Karaciğer Hastalıklarına Klinik Yaklaşım. Ed. Prof. Dr. Halil Değertekin, Prof. Dr. Kendal Yalçın, Diyarbakır,2009

9.Gastroenterolojide Anemnez ve Fizik Muayene. Propedötik

    kitapçığı, Ufuk Üniversitesi yayını, 2023.

 

 

C. SOSYAL İÇERİKLİ YAYINLAR

1.GAP ve Sağlık Sorunları (Rapor), Dicle Üniversitesi, 1992.

2.Diyarbakır Surlarının Dünü, Bugünü ve Yarını, Diyarbakır Tanıtma ve Kültür Vakfı Yayını, Diyarbakır, 1993.

3.Mardin Kapı Şen Oldu, Diyarbakır, Diyarbakır Tanıtma ve Kültür Vakfı Yayını, Diyarbakır, 1998.

4.The City Walls of Diyarbakır, (İngilizce). Diyarbakır Tanıtma ve Kültür Vakfı, Diyarbakır, 2000.

5.Dünden Bugüne Diyarbakır, CD Çalışması, Diyarbakır, 2001.

6.Diyarbakır Surları Kitabeler ve Kabartmalar. Diyarbakır Tanıtma ve Kültür Vakfı Yayını. Fotoğraf Albümü (Düzenleyen; Ozan Sağdıç)

   Ankara, 2003.